KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Amortization of Deferred Charges (2016)

Charles River Laboratories International has reported Amortization of Deferred Charges over the past 7 years, most recently at $506000.0 for Q4 2016.

  • For Q4 2016, Amortization of Deferred Charges rose 23.41% year-over-year to $506000.0; the TTM value through Dec 2016 reached $2.8 million, up 18.95%, while the annual FY2016 figure was $2.8 million, 18.95% up from the prior year.
  • Amortization of Deferred Charges for Q4 2016 was $506000.0 at Charles River Laboratories International, up from $34000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $4.6 million in Q1 2013 and troughed at $34000.0 in Q3 2016.
  • A 5-year average of $1.7 million and a median of $436000.0 in 2013 define the central range for Amortization of Deferred Charges.
  • Biggest five-year swings in Amortization of Deferred Charges: surged 165.36% in 2015 and later crashed 91.46% in 2016.
  • Year by year, Amortization of Deferred Charges stood at $4.5 million in 2012, then plummeted by 90.26% to $437000.0 in 2013, then fell by 2.29% to $427000.0 in 2014, then dropped by 3.98% to $410000.0 in 2015, then grew by 23.41% to $506000.0 in 2016.
  • Business Quant data shows Amortization of Deferred Charges for CRL at $506000.0 in Q4 2016, $34000.0 in Q3 2016, and $1.9 million in Q2 2016.